BACKGROUND & AIMS: There has been consistent evidence for a relationship between smoking and colorectal cancer (CRC), although it is not clear whether the colon or rectum is more sensitive to the effects of smoking. We investigated the relationships between cigarette smoking and risk of CRC and tumor location. METHODS: We analyzed data from 465,879 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study; 2741 developed CRC during the follow-up period (mean, 8.7 years). Cox proportional hazard regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: The risk of colon carcinoma was increased among ever smokers (HR, 1.18; 95% CI, 1.06-1.32) and former cigarette smokers (HR, 1.21; 95% CI, 1.08-1.36), compared with never smokers; the increased risk for current smokers was of borderline significance (HR, 1.13; 95% CI, 0.98-1.31). When stratified for tumor location, the risk of proximal colon cancer was increased for former (HR, 1.25; 95% CI, 1.04-1.50) and current smokers (HR, 1.31; 95% CI, 1.06-1.64), but the risks for cancers in the distal colon or rectum were not. Subsite analyses showed a nonsignificant difference between the proximal and distal colon (P = .45) for former smokers and a significant difference for current smokers (P = .02). For smokers who had stopped smoking for at least 20 years, the risk of developing colon cancer was similar to that of never smokers. CONCLUSIONS: Ever smokers have an increased risk of colon cancer, which appeared to be more pronounced in the proximal than the distal colon location.
BACKGROUND & AIMS: There has been consistent evidence for a relationship between smoking and colorectal cancer (CRC), although it is not clear whether the colon or rectum is more sensitive to the effects of smoking. We investigated the relationships between cigarette smoking and risk of CRC and tumor location. METHODS: We analyzed data from 465,879 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study; 2741 developed CRC during the follow-up period (mean, 8.7 years). Cox proportional hazard regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: The risk of colon carcinoma was increased among ever smokers (HR, 1.18; 95% CI, 1.06-1.32) and former cigarette smokers (HR, 1.21; 95% CI, 1.08-1.36), compared with never smokers; the increased risk for current smokers was of borderline significance (HR, 1.13; 95% CI, 0.98-1.31). When stratified for tumor location, the risk of proximal colon cancer was increased for former (HR, 1.25; 95% CI, 1.04-1.50) and current smokers (HR, 1.31; 95% CI, 1.06-1.64), but the risks for cancers in the distal colon or rectum were not. Subsite analyses showed a nonsignificant difference between the proximal and distal colon (P = .45) for former smokers and a significant difference for current smokers (P = .02). For smokers who had stopped smoking for at least 20 years, the risk of developing colon cancer was similar to that of never smokers. CONCLUSIONS: Ever smokers have an increased risk of colon cancer, which appeared to be more pronounced in the proximal than the distal colon location.
Authors: Fränzel J B van Duijnhoven; Akke Botma; Renate Winkels; Fokko M Nagengast; Hans F A Vasen; Ellen Kampman Journal: Fam Cancer Date: 2013-06 Impact factor: 2.375
Authors: Isabel de la Torre; Francisco Javier Díaz; Míriam Antón; Esteban Barragán; Joel Rodrigues; Celina Pires Journal: J Med Syst Date: 2011-05-06 Impact factor: 4.460
Authors: Jian Gong; Carolyn Hutter; John A Baron; Sonja Berndt; Bette Caan; Peter T Campbell; Graham Casey; Andrew T Chan; Michelle Cotterchio; Charles S Fuchs; Steven Gallinger; Edward Giovannucci; Tabitha Harrison; Richard Hayes; Li Hsu; Shuo Jiao; Yi Lin; Noralane M Lindor; Polly Newcomb; Bethann Pflugeisen; Amanda I Phipps; Thomas Rohan; Robert Schoen; Daniela Seminara; Martha L Slattery; Deanna Stelling; Fridtjof Thomas; Greg Warnick; Emily White; John Potter; Ulrike Peters Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-09-20 Impact factor: 4.254
Authors: J M Ordóñez-Mena; V Walter; B Schöttker; M Jenab; M G O'Doherty; F Kee; B Bueno-de-Mesquita; P H M Peeters; B H Stricker; R Ruiter; A Hofman; S Söderberg; P Jousilahti; K Kuulasmaa; N D Freedman; T Wilsgaard; A Wolk; L M Nilsson; A Tjønneland; J R Quirós; F J B van Duijnhoven; P D Siersema; P Boffetta; A Trichopoulou; H Brenner Journal: Ann Oncol Date: 2018-02-01 Impact factor: 32.976
Authors: Amanda J Cross; Simina Boca; Neal D Freedman; Neil E Caporaso; Wen-Yi Huang; Rashmi Sinha; Joshua N Sampson; Steven C Moore Journal: Carcinogenesis Date: 2014-03-19 Impact factor: 4.944
Authors: Reiko Nishihara; Teppei Morikawa; Aya Kuchiba; Paul Lochhead; Mai Yamauchi; Xiaoyun Liao; Yu Imamura; Katsuhiko Nosho; Kaori Shima; Ichiro Kawachi; Zhi Rong Qian; Charles S Fuchs; Andrew T Chan; Edward Giovannucci; Shuji Ogino Journal: Am J Epidemiol Date: 2013-06-20 Impact factor: 4.897